The percentage of AQP4-positive AD astrocytes was significantly higher (8.5 ± 4.8%) in comparison with those derived from controls, where the expression of this marker was almost absent (1.1 ± 0.5%, p < 0.01). Here, AQP4 is linked to Alzheimer disease.